Long-Term Risk of Breast Cancer after Diagnosis of Benign Breast Disease by Screening Mammography.


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
24 02 2022
Historique:
received: 25 11 2021
revised: 11 02 2022
accepted: 18 02 2022
entrez: 10 3 2022
pubmed: 11 3 2022
medline: 15 4 2022
Statut: epublish

Résumé

Assessing the long-term risk of breast cancer after diagnosis of benign breast disease by mammography is of utmost importance to design personalised screening strategies. We analysed individual-level data from 778,306 women aged 50-69 years with at least one mammographic screening participation in any of ten breast cancer screening centers in Spain from 1996 to 2015, and followed-up until 2017. We used Poisson regression to compare the rates of incident breast cancer among women with and without benign breast disease. During a median follow-up of 7.6 years, 11,708 (1.5%) women had an incident of breast cancer and 17,827 (2.3%) had a benign breast disease. The risk of breast cancer was 1.77 times higher among women with benign breast disease than among those without (95% CI: 1.61 to 1.95). The relative risk increased to 1.99 among women followed for less than four years, and remained elevated for two decades, with relative risk 1.96 (95% CI: 1.32 to 2.92) for those followed from 12 to 20 years. Benign breast disease is a long-term risk factor for breast cancer. Women with benign breast disease could benefit from closer surveillance and personalized screening strategies.

Identifiants

pubmed: 35270331
pii: ijerph19052625
doi: 10.3390/ijerph19052625
pmc: PMC8909630
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

N Engl J Med. 1994 Jul 7;331(1):10-5
pubmed: 8202095
Cancer Causes Control. 2010 Jun;21(6):821-8
pubmed: 20084540
PLoS One. 2021 Mar 23;16(3):e0248930
pubmed: 33755692
Ann Oncol. 2008 Apr;19(4):614-22
pubmed: 18024988
Eur Radiol. 2021 Jul;31(7):4839-4847
pubmed: 33409776
Eur J Obstet Gynecol Reprod Biol. 2016 May;200:16-23
pubmed: 26967341
Ann Surg Oncol. 2018 Oct;25(10):2795-2800
pubmed: 29968026
Breast Cancer Res. 2015 Dec 01;17(1):147
pubmed: 26627479
Radiology. 2013 Mar;266(3):752-8
pubmed: 23249570
J Clin Oncol. 2015 Oct 1;33(28):3137-43
pubmed: 26282663
Ann Intern Med. 2011 Jul 5;155(1):10-20
pubmed: 21727289
J Natl Cancer Inst. 2013 Jul 17;105(14):1043-9
pubmed: 23744877
J Natl Cancer Inst. 2004 Apr 21;96(8):616-20
pubmed: 15100339
Ann Intern Med. 2020 Jan 7;172(1):46-56
pubmed: 31766052
Stat Med. 2004 Apr 15;23(7):1111-30
pubmed: 15057881
Radiology. 2011 Feb;258(2):388-95
pubmed: 21273520
PLoS One. 2014 Feb 03;9(2):e86858
pubmed: 24498285
Br J Cancer. 2019 Jul;121(1):76-85
pubmed: 31114019
Ann Oncol. 2010 May;21 Suppl 3:iii43-51
pubmed: 20427360
Eur J Epidemiol. 2007;22(7):447-55
pubmed: 17594526
N Engl J Med. 2005 Jul 21;353(3):229-37
pubmed: 16034008
Breast Cancer Res Treat. 2015 Feb;149(3):569-75
pubmed: 25636589
N Engl J Med. 1985 Jan 17;312(3):146-51
pubmed: 3965932
Stat Med. 2007 May 20;26(11):2389-430
pubmed: 17031868
Breast J. 2015 Mar-Apr;21(2):168-74
pubmed: 25669425
Breast Cancer Res Treat. 2015 Jan;149(1):237-44
pubmed: 25503778

Auteurs

Marta Román (M)

Epidemiology and Evaluation Department, IMIM (Hospital del Mar Medical Research Institute), 08003 Barcelona, Spain.
Research Network on Health Services in Chronic Diseases (REDISSEC), 08003 Barcelona, Spain.

Javier Louro (J)

Epidemiology and Evaluation Department, IMIM (Hospital del Mar Medical Research Institute), 08003 Barcelona, Spain.
Research Network on Health Services in Chronic Diseases (REDISSEC), 08003 Barcelona, Spain.

Margarita Posso (M)

Epidemiology and Evaluation Department, IMIM (Hospital del Mar Medical Research Institute), 08003 Barcelona, Spain.
Research Network on Health Services in Chronic Diseases (REDISSEC), 08003 Barcelona, Spain.

Carmen Vidal (C)

Cancer Prevention and Monitoring Program, Catalan Institute of Oncology (ICO), 08908 Barcelona, Spain.

Xavier Bargalló (X)

Department of Radiology, Hospital Clinic, 08036 Barcelona, Spain.

Ivonne Vázquez (I)

Pathology Department, IMIM (Hospital del Mar Medical Research Institute), 08003 Barcelona, Spain.

María Jesús Quintana (MJ)

Department of Clinical Epidemiology and Public Health, University Hospital de la Santa Creu i Sant Pau, 08025 Barcelona, Spain.

Rodrigo Alcántara (R)

Radiology Department, IMIM (Hospital del Mar Medical Research Institute), 08003 Barcelona, Spain.

Francina Saladié (F)

Epidemiology and Cancer Prevention Service, Hospital Universitari Sant Joan de Reus, IISPV, 43204 Reus, Spain.

Javier Del Riego (J)

Department of Radiology, Parc Taulí University Hospital-UAB, 08208 Sabadell, Spain.

Lupe Peñalva (L)

Breast Cancer Screening Technical Office, Private Foundation Asil Hospital, 08402 Granollers, Spain.

Maria Sala (M)

Epidemiology and Evaluation Department, IMIM (Hospital del Mar Medical Research Institute), 08003 Barcelona, Spain.
Research Network on Health Services in Chronic Diseases (REDISSEC), 08003 Barcelona, Spain.

Xavier Castells (X)

Epidemiology and Evaluation Department, IMIM (Hospital del Mar Medical Research Institute), 08003 Barcelona, Spain.
Research Network on Health Services in Chronic Diseases (REDISSEC), 08003 Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH